Role of Chromogranin A-derived Fragments as Biomarkers for Pancreatic Neuroendocrine Tumors (PanNET)

被引：0
|
作者：
Andreasi, V. [1 ,2 ]
Partelli, S. [1 ]
Manzoni, M. [3 ]
Colombo, B. [2 ]
Muffatti, F. [1 ]
Corti, A. [2 ]
Falconi, M. [1 ]
机构：
[1] Univ Vita Salute San Raffaele, Pancreat Surg Unit, Pancreas Translat & Clin Res Ctr, Milan, Italy
[2] Univ Vita Salute San Raffaele, Tumor Biol & Vasc Targeting Unit, Expt Oncol, Milan, Italy
[3] Univ Vita Salute San Raffaele, San Raffaele Sci Inst, IRCCS, Endocrinol Unit, Milan, Italy
来源：
PANCREAS | 2021年 / 50卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
O-8
引用
收藏
页码：465 / 466
页数：2
相关论文
共 50 条
  • [31] A New Immunohistochemistry Prognostic Score (IPS) for Recurrence and Survival in Pancreatic Neuroendocrine Tumors (PanNET)
    Viudez, Antonio
    Carvalho, Filipe L. F.
    Maleki, Zahra
    Zahurak, Marianna
    Laheru, Daniel
    Stark, Alejandro
    Azad, Nilofer S.
    Wolfgang, Christopher L.
    Baylin, Stephen
    Herman, James G.
    De Jesus-Acosta, Ana
    LABORATORY INVESTIGATION, 2016, 96 : 205A - 205A
  • [32] ARX Reactivity Predicts Recurrence in Non-Functional Pancreatic Neuroendocrine Tumors (panNET)
    Neyaz, Azfar
    Patil, Deepa
    Deshpande, Vikram
    MODERN PATHOLOGY, 2020, 33 (SUPPL 2) : 1665 - 1666
  • [33] A New Immunohistochemistry Prognostic Score (IPS) for Recurrence and Survival in Pancreatic Neuroendocrine Tumors (PanNET)
    Viudez, Antonio
    Carvalho, Filipe L. F.
    Maleki, Zahra
    Zahurak, Marianna
    Laheru, Daniel
    Stark, Alejandro
    Azad, Nilofer S.
    Wolfgang, Christopher L.
    Baylin, Stephen
    Herman, James G.
    De Jesus-Acosta, Ana
    MODERN PATHOLOGY, 2016, 29 : 205A - 205A
  • [34] Utility of Serum Chromogranin B Compared with Chromogranin A as a Biomarker in Japanese Patients with Pancreatic Neuroendocrine Tumors
    Miki, M.
    Ito, T.
    Hijioka, M.
    Kawabe, K.
    Jensen, R. T.
    NEUROENDOCRINOLOGY, 2017, 105 : 157 - 157
  • [35] Change in Chromogranin A correlates with computed tomography imaging in pancreatic neuroendocrine tumors
    Jensen, K. H.
    Hilsted, L.
    Andersen, J. F. B.
    Mynster, T.
    Knigge, U.
    REGULATORY PEPTIDES, 2012, 177 : S22 - S22
  • [36] Chromogranin A is a reliable serum diagnostic biomarker for pancreatic neuroendocrine tumors but not for insulinomas
    Qiao, Xin-Wei
    Qiu, Ling
    Chen, Yuan-Jia
    Meng, Chang-Ting
    Sun, Zhao
    Bai, Chun-Mei
    Zhao, Da-Chun
    Zhang, Tai-Ping
    Zhao, Yu-Pei
    Song, Yu-Li
    Wang, Yu-Hong
    Chen, Jie
    Lu, Chong-Mei
    BMC ENDOCRINE DISORDERS, 2014, 14
  • [37] Age is an independent Predictor of Chromogranin A Levels in Patients with pancreatic neuroendocrine Tumors
    Overheu, O.
    Gisder, D. M.
    Nopel-Dunnebacke, S.
    Janot, M.
    Uhl, W.
    Tannapfel, A.
    Reinacher-Schick, A.
    ONCOLOGY RESEARCH AND TREATMENT, 2022, 45 (SUPPL 2) : 155 - 155
  • [38] Chromogranin A levels to predict survival in resectable pancreatic neuroendocrine tumors.
    Tariq, Khurram Bilal
    Roberts, Brandon
    Kapoor, Asha Nayak
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [39] Chromogranin A is a reliable serum diagnostic biomarker for pancreatic neuroendocrine tumors but not for insulinomas
    Xin-Wei Qiao
    Ling Qiu
    Yuan-Jia Chen
    Chang-Ting Meng
    Zhao Sun
    Chun-Mei Bai
    Da-Chun Zhao
    Tai-Ping Zhang
    Yu-Pei Zhao
    Yu-Li Song
    Yu-Hong Wang
    Jie Chen
    Chong-Mei Lu
    BMC Endocrine Disorders, 14
  • [40] Serum chromogranin A is a useful marker for Japanese patients with pancreatic neuroendocrine tumors
    Hijioka, Masayuki
    Ito, Tetsuhide
    Igarashi, Hisato
    Fujimori, Nao
    Lee, Lingaku
    Nakamura, Taichi
    Jensen, Robert T.
    Takayanagi, Ryoichi
    CANCER SCIENCE, 2014, 105 (11) : 1464 - 1471
12345